| Particulars |
| Company Name |
Venmax Drugs & Pharmaceuticals Ltd |
Year End |
202503 |
| Full Year |
| Equity (Rs Cr.) |
5.24 |
B.V. Rs |
8.40 |
| Sales Rs Cr. |
0.81 |
NP Rs Cr. |
-0.01 |
| NP Var% |
-116.00 |
Div% |
0.00 |
| CPS Rs |
0.00 |
EPS Rs |
0.00 |
| Traded Value(Rs Lakhs) |
1.91 |
52 Week High |
31.00 |
| 52 Week Low |
6.00 |
Price BSE |
30.00 |
| Price NSE |
0.00 |
Market Capital(Rs Cr.) |
15.46 |
| P/C Ratio |
-3,834.10 |
P/E Ratio |
-1,497.10 |
| Price Vs.BV |
3.57 |
|
| Latest Quarter |
| Year End |
202506 |
Sales Rs Cr. |
1.21 |
| NP Rs Cr. |
0.04 |
NP Var % |
246.00 |
| Trailing Twelve Months |
| Year End |
202506 |
Sales |
0.28 |
| OPM |
-133.37 |
NP |
-0.22 |
| NP Var% |
-72.08 |
EPS |
0.03 |
| PE |
0.00 |
|
|